Will Insurance or a Government Scheme — Pay for Imatinib?

PM-JAY primarily covers hospitalisation and procedure-based packages, not medicines bought from a retail pharmacy for home use. Imatinib is an oral tablet taken daily at home, which puts it outside the main scope of PM-JAY coverage for most patients. However, if you are admitted to a PM-JAY empanelled hospital for a related procedure, medicines administered during that admission may be included in the procedure package. The PM-JAY help desk at your empanelled hospital can confirm which packages cover your specific diagnosis and whether imatinib is included.

You cannot apply directly as a patient. Your treating oncologist completes a patient enrolment form through The Max Foundation, which administers GIPAP in India. The application includes your diagnosis documents, income evidence, and a declaration that you are not already receiving coverage from another source. Approval typically takes several weeks. If your oncologist is not familiar with GIPAP, ask them to contact The Max Foundation directly — the programme has been running in India for many years and the process is well established.

CGHS reimburses imatinib at the NPPA ceiling price, which is the maximum regulated price for the molecule in India. This is lower than the retail price of branded Glivec but covers the cost of DCGI-approved generics at most pharmacies. You can get the prescription dispensed at a CGHS wellness centre or approved pharmacy, or buy it yourself and claim reimbursement — the self-purchase route is slower but works. If your oncologist is not at a CGHS empanelled hospital, ask a CGHS wellness centre about the referral process for specialist prescriptions.

Most private health insurance policies in India cover hospitalisation, not outpatient medicines. Since imatinib is taken as a daily oral tablet at home, it typically falls outside standard inpatient cover. Some policies have a specific outpatient drug benefit or a critical illness rider that covers cancer medicines — look for 'oral chemotherapy' clauses in your policy document. If you are newly diagnosed, a pre-existing condition waiting period will almost certainly apply before any claim can be made on a policy taken out after diagnosis.

Both Aarogyasri (Telangana) and YSR Aarogyasri (Andhra Pradesh) cover cancer procedures at empanelled hospitals for eligible families. Coverage is assigned by procedure package, so surgery, biopsy, and some infusion-based chemotherapy sessions may be included, but a daily oral tablet taken at home is generally not covered as a separate medicine benefit. What is available depends on which procedure packages your empanelled hospital is authorised for. Confirm at the Aarogyasri help desk at your treating hospital before assuming coverage.

Speak to the hospital's social worker first — many oncology hospitals have a patient welfare desk with access to hardship funds or partner NGO support. Organisations including the Indian Cancer Society and CanSupport provide medicine assistance in some situations. GIPAP is also specifically designed for patients who cannot afford the medicine: your oncologist can initiate an assessment even if you have only explored the generic price so far, because eligibility is based on household income, not on a comparison with any particular medicine price.